Salicylate Poisoning — Alkalinization and Dialysis

Key Points

• Interpret salicylate concentration together with pH, symptoms, timing, renal function, and acute versus chronic exposure.
• Serial salicylate levels are required until the concentration clearly peaks and declines with clinical improvement.
• Respiratory alkalosis plus anion-gap metabolic acidosis is classic, but acid-base patterns vary by timing and age.
• IV sodium bicarbonate protects the CNS through serum alkalinization and enhances renal elimination through urine alkalinization.
• Correct hypokalemia because potassium depletion prevents effective urinary alkalinization.
• Avoid unnecessary intubation; loss of compensatory hyperventilation can abruptly worsen acidemia and CNS salicylate penetration.
• Altered mental status and salicylate-associated hypoxemia are major indications for early hemodialysis regardless of whether a traditional concentration threshold has been reached.
• Intermittent hemodialysis is the preferred extracorporeal treatment for severe salicylate poisoning.

Algorithm

1. Assess airway, breathing, circulation, temperature, neurologic status, and the acute versus chronic exposure history.
2. Obtain salicylate concentration, blood gas, electrolytes, glucose, creatinine, ECG, and acetaminophen concentration in intentional or uncertain overdose.
3. Repeat salicylate levels and acid-base studies until a peak and sustained decline are established.
4. Give activated charcoal when appropriate and the airway is protected.
5. Correct volume depletion and potassium deficiency while beginning IV sodium bicarbonate for significant toxicity.
6. Titrate alkalinization to a mildly alkalemic serum pH and urine pH approximately 7.5 to 8.0, with frequent electrolyte monitoring.
7. Treat neuroglycopenic symptoms with dextrose and seizures with benzodiazepines.
8. Avoid intubation if possible; if required, minimize apnea and preserve the patient's high minute ventilation.
9. Consult nephrology early for altered mental status, hypoxemia, renal failure, severe acidosis, inability to alkalinize, very high level, or clinical deterioration.
10. Use intermittent hemodialysis for severe poisoning and continue post-dialysis monitoring for rebound when clinically relevant.

Clinical Synopsis & Reasoning

Salicylate toxicity can follow acute overdose, repeated supratherapeutic use, or chronic accumulation, and the clinical pattern differs substantially between these settings. Early acute toxicity often causes nausea, vomiting, diaphoresis, tinnitus, vertigo, tachypnea, and respiratory alkalosis from direct medullary stimulation. As toxicity progresses, uncoupling of oxidative phosphorylation and accumulation of organic acids produce a mixed respiratory alkalosis and anion-gap metabolic acidosis. Hyperthermia, dehydration, hypokalemia, altered mental status, seizure, noncardiogenic pulmonary edema, hypoglycemia at the tissue level, and multiorgan failure can develop.

A single serum salicylate concentration is never sufficient for risk assessment. Absorption can be delayed by enteric-coated preparations, bezoar formation, pylorospasm, or a large tablet burden, and concentrations can continue to rise for many hours. Obtain serial levels until there is a clear peak and sustained decline while the patient is clinically improving. Chronic toxicity and toxicity in older adults or patients with kidney disease can be severe at concentrations that would be less alarming in a young patient after a single acute ingestion. Clinical deterioration despite a falling serum concentration can occur as salicylate shifts into tissues, especially if serum pH falls.

Acid-base status is central to pathophysiology. As blood pH decreases, a greater fraction of salicylic acid is nonionized and can cross the blood-brain barrier, increasing CNS toxicity. The patient may maintain an extremely high spontaneous minute ventilation to compensate for metabolic acidosis. Suppressing that ventilation during sedation or intubation can cause a sudden fall in pH and catastrophic increase in tissue salicylate penetration. Normal serum glucose does not guarantee adequate CNS glucose availability, and dextrose may improve neurologic symptoms even without measured hypoglycemia in severe toxicity.

Treatment Strategy & Disposition

Contact a poison center or medical toxicologist early. Provide supportive care, correct significant dehydration, and administer activated charcoal after a potentially serious recent ingestion when the airway is protected. Because absorption can be delayed, selected large or enteric-coated ingestions may warrant additional gastrointestinal decontamination under toxicology guidance. Measure salicylate concentrations and acid-base status serially.

IV sodium bicarbonate is a cornerstone of significant salicylate poisoning because serum alkalinization reduces CNS penetration and urinary alkalinization greatly increases renal salicylate elimination. A commonly used infusion contains 150 mEq sodium bicarbonate in 1 L of dextrose-containing fluid, with potassium supplementation when appropriate, titrated to a mildly alkalemic serum pH and urine pH about 7.5 to 8.0. Hypokalemia makes urinary alkalinization difficult because the kidney retains potassium in exchange for hydrogen ion secretion, so potassium should be corrected aggressively while avoiding unsafe replacement in renal failure. Volume status must also be restored enough for bicarbonate delivery and urine flow. Acetazolamide is not recommended because it can lower serum pH even if urine becomes alkaline.

Avoid intubation unless it is truly necessary for airway protection or respiratory failure. If intubation cannot be avoided, minimize apnea, give bicarbonate before and during the procedure when appropriate, and immediately match or exceed the patient's preintubation minute ventilation as safely as possible. A drop in pH after intubation can be fatal. Seizures are treated with benzodiazepines, while dextrose should be given for hypoglycemia and can be considered for significant neuroglycopenic manifestations even when measured serum glucose is not low.

Hemodialysis removes salicylate, corrects acid-base and electrolyte abnormalities, and manages volume overload. Do not delay nephrology and dialysis planning until a rigid concentration threshold is crossed if severe clinical features are present. EXTRIP recommends extracorporeal treatment for altered mental status, new hypoxemia requiring supplemental oxygen, serum salicylate above 100 mg/dL, or above 90 mg/dL in impaired kidney function, and in other severe situations where standard treatment is failing. Intermittent hemodialysis is the preferred modality. Chronic toxicity, progressive acidosis, renal failure, pulmonary edema, inability to alkalinize, or clinical deterioration at lower concentrations can justify dialysis at a lower numeric level.

Epidemiology / Risk Factors

• Aspirin remains the most common clinically important salicylate exposure, but oil of wintergreen and other salicylate-containing products can also produce severe poisoning.
• Chronic toxicity disproportionately affects older adults and patients with reduced kidney function.
• Enteric-coated tablets can produce delayed peaks after acute overdose.
• Children may develop prominent metabolic acidosis and neurologic toxicity with less obvious respiratory alkalosis.
• Therapeutic misadventure from repeated dosing can be more difficult to recognize than an intentional acute ingestion.
• Coingestion with other drugs can obscure the characteristic tachypnea or neurologic picture.

Investigations

Dialysis Indications (Examples)

Pharmacology

Prognosis / Complications

• Patients treated before severe CNS toxicity, pulmonary edema, or refractory acidosis generally recover well.
• Delayed hemodialysis in a patient with severe clinical toxicity is associated with worse outcome.
• Chronic poisoning can be lethal at lower serum concentrations than acute poisoning.
• Progressive acidemia is a particularly dangerous sign because it increases tissue and CNS salicylate penetration.
• Neurologic recovery can be excellent after dialysis when treatment occurs before irreversible injury.
• Rebound after dialysis or delayed absorption after a large ingestion requires continued clinical and laboratory observation.

Patient Education / Counseling

• Advise patients to read labels because salicylates can be present in multiple over-the-counter products.
• Older adults and patients with kidney disease should avoid repeated high-dose aspirin use without medical supervision.
• Parents should store aspirin, bismuth-containing products, and concentrated methyl salicylate securely away from children.
• After intentional overdose, provide mental-health evaluation and reduce access to large medication quantities when appropriate.
• Seek urgent care for tinnitus, persistent vomiting, unusual rapid breathing, confusion, or suspected large ingestion.
• Do not attempt home treatment with baking soda or induce vomiting after a suspected overdose; contact emergency services or a poison center.

Notes

Salicylate poisoning is a condition in which physiology matters more than a single drug level. Serum pH controls the fraction of salicylate able to cross into tissues, so a patient can worsen while the measured concentration falls if acidemia develops. Serial concentrations must therefore be interpreted with blood gases, renal function, neurologic status, and oxygenation.

The American College of Medical Toxicology emphasizes serum and urine alkalinization with IV sodium bicarbonate for significant toxicity. Urine pH of approximately 7.5 to 8.0 can increase salicylate excretion dramatically, but effective alkalinization requires adequate potassium and renal function.

EXTRIP recommends intermittent hemodialysis for severe salicylate poisoning and specifically identifies altered mental status, new hypoxemia requiring oxygen, very high serum concentrations, and impaired renal function as major triggers. In practice, chronic toxicity and clinical deterioration justify a lower threshold for dialysis than an isolated acute concentration might suggest.

References

1. American College of Medical Toxicology Guidance Document: Management Priorities in Salicylate Toxicity — Link
2. EXTRIP Workgroup Recommendations for Salicylates — Link